Aurobindo Pharma Ltd

Overview

Aurobindo Pharma Ltd (Aurobindo) is a vertically integrated pharmaceutical company that manufactures and markets generic pharmaceuticals and active pharmaceutical ingredients (APIs). Its product portfolio is spread across major therapeutic and product categories including antibiotics, anti-retroviral, systemic gastroenterological, central nervous system, cardiovascular, anti-allergies, anti-diabetics, other therapeutic areas. The company also produces novel proprietary biocatalysts, dietary supplements and fermentation based semi synthetic products. Aurobindo operates manufacturing facilities in India, Brazil, Portugal and the US; and R&D facilities in India and the US. The company exports products to several countries worldwide. Aurobindo is headquartered in Hyderabad, Telangana, India.
Key Stats
Address
Water Mark Building, , Plot No. 11, Survey no.9, Kondapur, Hitech City, Ameerpet, HYDERABAD, India
Headquarters

India

Contact

91 40 66725000

No of Employees

19,364

Industry

Pharmaceuticals and Healthcare

Ticker Symbol & Exchange​

AUROPHARMA [NSE]

Revenue (2021)

$3,353 m

7.3% (2021 vs 2020)
Net Income (2021)

$722 m

87.5% (2021 vs 2020)
Net Profit Margin

22 %

74.8% (2021 vs 2020)
Market Cap *

$5,960 m

EPS *

$1.2

  *Note: Ratios based on the share price as of 8-September-2021, in absolute numbers and US$.

Peer Comparison

Key Parameters Aurobindo Pharma LtdSun Pharmaceutical Industries LtdCipla LtdDr. Reddy's Laboratories Ltd
Key Information
Headquarters India India India India
Headquarter City HYDERABAD MUMBAI MUMBAI HYDERABAD
Headquarter State/Province - - - -
No. of Employees 19,364 37,000 21,565 22,739
Entity Type Public Public Public Public

Products & Services

Aurobindo Pharma Ltd (Aurobindo) is a fully integrated pharmaceutical company. It offers key products and services in the following therapeutic areas:

Products
  • Formulations:
  • Antibacterials:
  • Cephalosporins
  • Vitae Eget Libero
  • Vitae Eget Libero
  • Vitae Eget Libero
  • Vitae Eget Libero
  • Vitae Eget Libero
  • Vitae Eget Libero
  • Vitae Eget Libero
Services
  • Contract Manufacturing:
  • Analytical Services
  • API Biologics (Protein and Peptide)
  • Etiam Rutrum Elit
  • Etiam Rutrum Elit
  • Etiam Rutrum Elit
  • Etiam Rutrum Elit
  • Etiam Rutrum Elit
  • Etiam Rutrum Elit
Key Financial Charts
Sales Growth
Operating Margin
Net Income Growth
EPS (Earnings per Share)
Debt to Equity Ratio
Return on Assets

Employees

Name Position Board Since Age Biography
Non Dignissim Eros Proin vel Convallis 2015 XX In vitae nisi ut tortor rutrum suscipit vel vitae ligula. Mauris sed tellus non augue ultricies ultricies. Aliquam vitae urna congue.
Non Dignissim Eros Proin vel Convallis 2015 XX In vitae nisi ut tortor rutrum suscipit vel vitae ligula. Mauris sed tellus non augue ultricies ultricies. Aliquam vitae urna congue.

History

Year Event Description
2021 Contracts/Agreements In February, the company entered into an agreement to acquire 26% stake in NVNR (Ramannapet…
2021 Acquisitions/Mergers/Takeovers In August, the company agreed to acquire a 51% stake in Cronus Pharma Specialities India…
2021 Regulatory Approval In August, the company received the US Food and Drug Administration approval for memantine hydrochloride…
2020 Quis autem vel Ut enim ad minima veniam, quis nostrum exercitationem ullam corporis suscipit laboriosam
2020 Quis autem vel Ut enim ad minima veniam, quis nostrum exercitationem ullam corporis suscipit laboriosam
2020 Quis autem vel Ut enim ad minima veniam, quis nostrum exercitationem ullam corporis suscipit laboriosam

Locations


Aurobindo Pharma USA Inc

Address

279 Princeton Hightstown Road, East Windsor
United States of America

Telephone

1 732 8399400

Website

www.aurobindousa.com
Aurobindo Pharma France Sarl

Address

22 - 26 rue des Gaudines, Saint Germain En Laye
France

Telephone

33 609 318105

APL Pharma Thai Ltd

Address

438, Soi Phattanakaran, 30 Road Suanluang, Bangkok
Thailand

Telephone

66 2 7195425

Helix Healthcare B.V.

Address

Prins Bernhardplein 200, P.O. Box 990, Amsterdam
Netherlands

Telephone

31 20 5214830

Aurobindo Pharma Japan KK

Address

Grand Cru 805, 1-1-27, Kitahama, Chuo-ku, Osaka
Japan

Telephone

81 60 61213018

Website

www.aurobindo.com
AuroPharma Inc

Address

3700 Steeles Avenue West, Suite 402, Woodbridge
Canada

Telephone

1 905 8568063

Website

auropharma.ca
Agile Pharma BV

Address

Prins Bernhardplein 200, P.O. Box 990, Amsterdam
Netherlands

Telephone

31 5214830

Aurobindo Pharma (Italia) Srl

Address

Via Pergolesi 15, Milan
Italy

Telephone

39 02 89289800

Website

www.aurobindo.com

Deals

Number of Deals
Deal Value (US$ m)

Latest Deals

Announced Date Headline Deal Type Acquirers / Investors / Surviving Entity Issuer / partner / Target
20 Aug 2021 Aurobindo Pharma Terminates Acquisition of 51% Stake in Cronus Pharma Specialties Acquisition Aurobindo Pharma Ltd Cronus Pharma Specialties India Pvt Ltd
01 Jul 2021 Eugia Pharma to Acquire Manufacture of Generic Injectables and Ophthalmics Business from Aurobindo Pharma Asset Transaction Eugia Pharma Specialties Ltd Aurobindo Pharma Ltd
21 May 2021 Heron Therapeutics Enters Manufacturing Agreement with Aurobindo Pharma for Zynrelef Contract Service Agreement Heron Therapeutics Inc Aurobindo Pharma Ltd
24 Feb 2021 Lorem ipsum dolor sit amet, consectetur adipiscing elit Eiusmod Tempor Exercitation cillum velit
24 Feb 2021 Lorem ipsum dolor sit amet, consectetur adipiscing elit Eiusmod Tempor Exercitation cillum velit
24 Dec 2020 Lorem ipsum dolor sit amet, consectetur adipiscing elit Eiusmod Tempor Exercitation cillum velit

Jobs Overview

114

Active Jobs

81

Posted

46

Closed

Job Trends

Latest Jobs

Job title Company Country
ASSOCIATE SCIENTIST Aurobindo Pharma Ltd India
ASSISTANT SCIENTIST Aurobindo Pharma Ltd India
Cras Malesuada Dolor nisi Lorem minim amet cillum elit. Cursus Sed Pulvinar
Cras Malesuada Dolor nisi Lorem minim amet cillum elit. Cursus Sed Pulvinar
Cras Malesuada Dolor nisi Lorem minim amet cillum elit. Cursus Sed Pulvinar
Cras Malesuada Dolor nisi Lorem minim amet cillum elit. Cursus Sed Pulvinar